133 related articles for article (PubMed ID: 21098846)
21. First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone.
Orlandi F; Rossi C; Orlandi E; Jakil MC; Hallahan TW; Macri VJ; Krantz DA
Am J Obstet Gynecol; 2005 Apr; 192(4):1107-11. PubMed ID: 15846188
[TBL] [Abstract][Full Text] [Related]
22. Genetic sonography after first-trimester Down syndrome screening.
Krantz DA; Hallahan TW; Macri VJ; Macri JN
Ultrasound Obstet Gynecol; 2007 Jun; 29(6):666-70. PubMed ID: 17492748
[TBL] [Abstract][Full Text] [Related]
23. Aberrant right subclavian artery: incidence and correlation with other markers of Down syndrome in second-trimester fetuses.
Paladini D; Sglavo G; Pastore G; Masucci A; D'Armiento MR; Nappi C
Ultrasound Obstet Gynecol; 2012 Feb; 39(2):191-5. PubMed ID: 21793087
[TBL] [Abstract][Full Text] [Related]
24. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
25. Interest of foetal nasal bone measurement at first trimester trisomy 21 screening.
Weingertner AS; Kohler M; Firtion C; Vayssière C; Favre R
Fetal Diagn Ther; 2006; 21(5):433-8. PubMed ID: 16912493
[TBL] [Abstract][Full Text] [Related]
26. Nasal bone length: prenasal thickness ratio: a strong 2D ultrasound marker for Down syndrome.
Szabó A; Szili K; Szabó JT; Sikovanyecz J; Isaszegi D; Horváth E; Szabó J
Prenat Diagn; 2014 Dec; 34(12):1139-45. PubMed ID: 24966049
[TBL] [Abstract][Full Text] [Related]
27. Systematic review and meta-analysis of performance of second-trimester nasal bone assessment in detection of fetuses with Down syndrome.
Moreno-Cid M; Rubio-Lorente A; Rodríguez MJ; Bueno-Pacheco G; Tenías JM; Román-Ortiz C; Arias Á
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):247-53. PubMed ID: 24151178
[TBL] [Abstract][Full Text] [Related]
28. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
29. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
30. PT/NBL ratio assessment at mid-trimester in prenatal screening for Down syndrome in a Chinese population.
Yang X; Zhen L; Pan M; Han J; Li D; Liao C
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1860-3. PubMed ID: 24476348
[TBL] [Abstract][Full Text] [Related]
31. Additional performance of nasal bone in first trimester screening.
Kozlowski P; Knippel AJ; Froehlich S; Stressig R
Ultraschall Med; 2006 Aug; 27(4):336-9. PubMed ID: 16596511
[TBL] [Abstract][Full Text] [Related]
32. Facial markers in second- and third-trimester fetuses with trisomy 18 or 13, triploidy or Turner syndrome.
Kagan KO; Sonek J; Berg X; Berg C; Mallmann M; Abele H; Hoopmann M; Geipel A
Ultrasound Obstet Gynecol; 2015 Jul; 46(1):60-5. PubMed ID: 25175793
[TBL] [Abstract][Full Text] [Related]
33. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.
Wright D; Spencer K; Kagan K K; Tørring N; Petersen OB; Christou A; Kallikas J; Nicolaides KH
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):404-11. PubMed ID: 20658511
[TBL] [Abstract][Full Text] [Related]
34. [News methods for second trimester screening of Down syndrome: statistical analysis of the use of nasal bone length and prenasal thickness].
Szili K; Szabó A; Vanya M; Bártfai G; Szabó J
Orv Hetil; 2014 Nov; 155(47):1876-81. PubMed ID: 25403282
[TBL] [Abstract][Full Text] [Related]
35. Defining nasal bone hypoplasia in second-trimester Down syndrome screening: does the use of multiples of the median improve screening efficacy?
Odibo AO; Sehdev HM; Stamilio DM; Cahill A; Dunn L; Macones GA
Am J Obstet Gynecol; 2007 Oct; 197(4):361.e1-4. PubMed ID: 17904959
[TBL] [Abstract][Full Text] [Related]
36. First-trimester sonographic screening for Down syndrome.
Malone FD; D'Alton ME;
Obstet Gynecol; 2003 Nov; 102(5 Pt 1):1066-79. PubMed ID: 14672489
[TBL] [Abstract][Full Text] [Related]
37. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
38. First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-β human chorionic gonadotrophin, placental growth factor, and α-fetoprotein.
Huang T; Dennis A; Meschino WS; Rashid S; Mak-Tam E; Cuckle H
Prenat Diagn; 2015 Jul; 35(7):709-16. PubMed ID: 25846403
[TBL] [Abstract][Full Text] [Related]
39. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.
Nicolaides KH
Am J Obstet Gynecol; 2004 Jul; 191(1):45-67. PubMed ID: 15295343
[TBL] [Abstract][Full Text] [Related]
40. Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome: thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone.
Bethune M
Australas Radiol; 2007 Jun; 51(3):218-25. PubMed ID: 17504311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
